EnQuest (LSE: ENQ) full-year 2025 results: Production up 5.4%, dividend raised as South East Asia pivot reshapes growth outlook
Can Southland Holdings, Inc. turn water and data center demand into a cleaner growth story? (NYSE American: SLND)
Read More 2 minute read Pharma Industry News Bristol-Myers Squibb partners with Compugen to trial COM701 and Opdivo combination for advanced solid tumors Bristol-Myers Squibb’s (BMS) latest clinical partnership with Israeli company Compugen is set to explore the efficacy of combining… bypharmanewsdailyOctober 13, 2018
